These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2888434)

  • 1. [A molecular basis for multidrug-resistance and reversal of resistance with human malignant cells].
    Akiyama S; Kikuchi H; Yoshimura A; Matsumoto M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2617-25. PubMed ID: 2888434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A molecular basis for multidrug resistance and reversal of the resistance].
    Akiyama S; Yoshimura A; Kikuchi H; Kamiwatari M; Nagata Y; Seto K; Sakota R; Utsunomiya A; Hanada S; Hashimoto S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1266-72. PubMed ID: 2567148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of multidrug resistance in tumor cells.
    Roninson IB
    Clin Physiol Biochem; 1987; 5(3-4):140-51. PubMed ID: 2887329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.
    Bates SE; Shieh CY; Mickley LA; Dichek HL; Gazdar A; Loriaux DL; Fojo AT
    J Clin Endocrinol Metab; 1991 Jul; 73(1):18-29. PubMed ID: 1675220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.
    Wu L; Smythe AM; Stinson SF; Mullendore LA; Monks A; Scudiero DA; Paull KD; Koutsoukos AD; Rubinstein LV; Boyd MR
    Cancer Res; 1992 Jun; 52(11):3029-34. PubMed ID: 1350507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
    Christensen JG; LeBlanc GA
    Cancer Res; 1996 Feb; 56(3):574-81. PubMed ID: 8564974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical MDR].
    Yokomizo A; Taniguchi K; Hasegawa S; Abe T; Kubo T; Makino Y; Wada M; Kohno K; Kuwano M
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1123-9. PubMed ID: 7913311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells.
    Mazzanti R; Croop JM; Gatmaitan Z; Budding M; Steiglitz K; Arceci R; Arias IM
    Oncol Res; 1992; 4(8-9):359-65. PubMed ID: 1362504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
    Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists as modulators of multi-drug resistant tumor cells].
    Hamilton G; Theyer G; Baumgartner G
    Wien Med Wochenschr; 1993; 143(19-20):526-32. PubMed ID: 7907828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multidrug resistance (MDR)].
    Wada M; Hasegawa S; Kohno K; Kuwano M
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):936-44. PubMed ID: 8002631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular basis for resistance to anticancer agents and reversal of the resistance].
    Akiyama S
    Hum Cell; 1993 Mar; 6(1):1-6. PubMed ID: 8102068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
    Krishna R; Mayer LD
    Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
    Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
    Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
    Hait WN; Choudhury S; Srimatkandada S; Murren JR
    J Clin Invest; 1993 May; 91(5):2207-15. PubMed ID: 8098047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope.
    Haus-Cohen M; Assaraf YG; Binyamin L; Benhar I; Reiter Y
    Int J Cancer; 2004 May; 109(5):750-8. PubMed ID: 14999785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of multidrug resistance of tumor cells.
    Kane SE; Pastan I; Gottesman MM
    J Bioenerg Biomembr; 1990 Aug; 22(4):593-618. PubMed ID: 1977744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidrug resistance of malignant tumors].
    Bak M
    Orv Hetil; 1991 Oct; 132(40):2187-92. PubMed ID: 1682863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.